What sets Alzheimer's apart from other dementias

Alzheimer's disease accounts for 60 to 80 percent of all dementia cases, but it is not the only form. The key difference is what happens in the brain: Alzheimer's involves the buildup of two proteins — amyloid and tau — that damage and kill nerve cells. Other dementias stem from different causes: vascular dementia follows strokes that cut off blood flow, Lewy body dementia involves protein deposits called Lewy bodies, and frontotemporal dementia damages the front and side lobes of the brain.

The symptoms can overlap enough to confuse diagnosis, but the progression and treatment paths often differ. Knowing which type a person has matters because some medications work only for Alzheimer's, some dementias progress faster than others, and the behaviors that emerge can be quite different. A doctor cannot tell by symptoms alone — diagnosis usually requires imaging, blood tests, or sometimes a spinal tap.

Key Takeaways

  • Alzheimer's involves amyloid and tau protein buildup in the brain, while vascular dementia results from stroke damage, Lewy body dementia from protein deposits, and frontotemporal dementia from damage to the front lobes.
  • Memory loss is the hallmark of Alzheimer's, whereas vascular dementia often causes sudden changes, Lewy body dementia brings visual hallucinations early, and frontotemporal dementia typically starts with personality or language changes.
  • Medications like donepezil and memantine are approved only for Alzheimer's and do not work for other dementia types.
  • Vascular dementia may slow or stabilize if strokes are prevented, while Alzheimer's and Lewy body dementia follow a more predictable decline.
  • A definitive diagnosis often requires brain imaging, blood biomarkers, or spinal fluid testing — not just a clinical exam.

Alzheimer's versus vascular dementia

Vascular dementia is the second most common form and develops when blood flow to the brain is reduced or blocked, usually by small strokes. The onset is often sudden — a person may wake up noticeably more confused or forgetful after a stroke — whereas Alzheimer's typically creeps in gradually over months or years. Vascular dementia also tends to affect reasoning and judgment before memory, while Alzheimer's usually takes memory first.

The progression differs too. Vascular dementia can plateau or even improve slightly if the person avoids further strokes through blood pressure control and medication. Alzheimer's follows a more predictable downward slope. Treatment also diverges: vascular dementia is managed by preventing future strokes (blood thinners, blood pressure drugs, lifestyle changes), while Alzheimer's medications target the protein buildup itself.

Alzheimer's versus Lewy body dementia

Lewy body dementia is caused by abnormal protein deposits called Lewy bodies that accumulate in the brain. It is the third most common dementia type. The hallmark symptom that separates it from Alzheimer's is visual hallucinations that appear early — people often see people, animals, or objects that are not there, and these visions feel very real. Alzheimer's patients rarely have hallucinations until late in the disease.

Lewy body dementia also brings movement problems similar to Parkinson's disease — stiffness, tremor, and slow movement — which Alzheimer's does not cause. Sleep disturbances are severe and often come first. The cognitive decline in Lewy body dementia fluctuates more day to day than Alzheimer's does. Medications used for Alzheimer's can actually make Lewy body dementia worse, particularly antipsychotics, which can trigger a dangerous reaction.

Alzheimer's versus frontotemporal dementia

Frontotemporal dementia (FTD) damages the front and side lobes of the brain and typically strikes people younger than Alzheimer's does — often in the 40s, 50s, or early 60s. The first sign is usually not memory loss but a change in personality, behavior, or language. A person might become withdrawn, lose empathy, or start making poor decisions. Others develop language problems — difficulty finding words or understanding speech — before any memory trouble appears.

Memory stays relatively intact in early FTD, which is the opposite of Alzheimer's. The disease progresses faster than Alzheimer's in many cases and is often inherited — if one parent had FTD, the risk to children is higher. There is no medication that slows FTD, so treatment focuses on managing behavior and language therapy.

How diagnosis works and why it matters

A doctor cannot diagnose dementia type by interview and physical exam alone. The process usually includes cognitive testing (memory, reasoning, language), brain imaging (MRI or CT scan to look for strokes, shrinkage, or other changes), and sometimes blood tests that measure amyloid and tau levels. A spinal tap, which measures the same proteins in cerebrospinal fluid, is more definitive but less commonly done.

Getting the type right matters because treatment paths diverge. Alzheimer's has three FDA-approved medications (donepezil, rivastigmine, galantamine) that slow decline for some people in early stages, plus memantine for moderate to advanced disease. Vascular dementia has no disease-modifying drugs — the focus is stroke prevention. Lewy body dementia has no approved treatments and requires careful medication choices to avoid harmful reactions. FTD has no slowing medications either.

Mixed dementia and diagnostic uncertainty

Many older adults have more than one type of dementia at the same time — for example, both Alzheimer's pathology and vascular damage. This is called mixed dementia and is common in people over 80. It can make diagnosis harder and means symptoms may not fit neatly into one category. A person might have the memory loss of Alzheimer's plus the sudden changes of vascular dementia.

Sometimes diagnosis remains uncertain even after testing. In those cases, doctors may treat based on the most likely type or manage symptoms broadly — controlling blood pressure, preventing strokes, managing behavior and mood — rather than targeting a specific disease. A neurologist or geriatrician can help sort through unclear cases.

What this means for care planning

Knowing the dementia type shapes decisions about medications, living arrangements, and what to expect. If someone has Alzheimer's, early treatment with a disease-modifying medication may be worth discussing. If vascular dementia is the diagnosis, the focus shifts to aggressive stroke prevention and managing cardiovascular risk. Lewy body dementia requires careful attention to medication side effects and often benefits from a specialist's input.

The type also affects which behaviors are most likely to emerge and how quickly decline will happen. This helps families and caregivers prepare — knowing whether to expect rapid change or a slower course, whether hallucinations are likely, and what safety concerns to prioritize. It also guides which support services and living situations make sense.

Frequently Asked Questions

Can someone have both Alzheimer's and vascular dementia at the same time?

Yes. Mixed dementia — having both Alzheimer's pathology and vascular damage — is common, especially in people over 80. Symptoms may include both the gradual memory loss of Alzheimer's and the sudden changes typical of strokes. Brain imaging and sometimes blood tests help identify both components.

Do the same medications work for all types of dementia?

No. Donepezil, rivastigmine, galantamine, and memantine are approved only for Alzheimer's disease. They do not slow other dementia types and may actually harm people with Lewy body dementia. Vascular dementia and frontotemporal dementia are managed through different approaches — stroke prevention for vascular, and symptom management for FTD.

Why do hallucinations happen in Lewy body dementia but not Alzheimer's?

Lewy bodies damage different brain regions than Alzheimer's does, particularly areas that control vision and perception. Visual hallucinations are a core feature of Lewy body dementia and often appear early, whereas Alzheimer's typically spares these regions until late stages.

Is frontotemporal dementia inherited?

About 40 percent of FTD cases run in families. If a parent had FTD, children have a 50 percent chance of inheriting the genetic mutation. Genetic testing can identify mutations in some families. Not all FTD is inherited, but family history is a significant risk factor.

How long does it take to get a diagnosis?

Diagnosis usually takes weeks to months. The process involves cognitive testing, brain imaging, and sometimes blood tests or a spinal tap. A primary care doctor may start the workup, but a neurologist or geriatrician often does the final diagnosis. If results are unclear, a second opinion or repeat imaging months later may be needed.